Join
Live feed
·
PRReleasevia Quantisnow
SciSparc Ltd. logo

SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome

ByQuantisnow·Wall Street's wire, on your screen.
SPRC· SciSparc Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SPRC (SciSparc Ltd.) and more on Quantisnow.